Studies

What is a Study?
1 Study visible to you, out of a total of 1

Multi-omics analysis for rare neurodevelopmental disorders. The material consists of patient-derived IPSCs from NANS, CDH2, and DM1 patients. In some cases the genotype was rescued using CRISPR/Cas9 gene editing. The studied omics include Genomics, Transcriptomics, DNA methylation, Proteomics, Glycoproteomics, Metabolomics, and Lipidomics.

Powered by
(v.1.16.1)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH